These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 6124062)
1. [Routes of body and tumor interaction]. Pinchuk VG; Balitskiĭ KP Vopr Onkol; 1982; 28(5):18-22. PubMed ID: 6124062 [No Abstract] [Full Text] [Related]
2. Neurohumoral mechanisms of the formation of antitumoral activity. Vinnitsky VB Ann N Y Acad Sci; 1988; 521():195-214. PubMed ID: 2897817 [No Abstract] [Full Text] [Related]
3. [Thymus hormones in the immunotherapy of malignant neoplasms (a review of the literature)]. Nikol'skiĭ IS Vrach Delo; 1988 Aug; (8):77-82. PubMed ID: 3061171 [No Abstract] [Full Text] [Related]
4. The gene therapy of cancer: transgenic immunotherapy. Zwiebel JA; Su N; MacPherson A; Davis T; Ojeifo JO Semin Hematol; 1993 Oct; 30(4 Suppl 4):119-28; discussion 129. PubMed ID: 8303305 [TBL] [Abstract][Full Text] [Related]
5. The change in tumor aggressiveness with age: lessons from experimental animals. Kaesberg PR; Ershler WB Semin Oncol; 1989 Feb; 16(1):28-33. PubMed ID: 2645646 [No Abstract] [Full Text] [Related]
6. [Cancer as a specific variant of the evolutionary resistance of adapted cells to damaging factors]. Monceviciūte-Eringiene E Vopr Onkol; 2000; 46(3):255-62. PubMed ID: 10976269 [No Abstract] [Full Text] [Related]
7. [Immunological properties of tumor cells that determine the degree of their malignancy]. Lavrovskiĭ VA; Viksler VKh Usp Sovrem Biol; 1981; 91(2):228-40. PubMed ID: 7018110 [No Abstract] [Full Text] [Related]
8. Hyperthermia: the immune response and tumor metastasis. Dickson JA; Shah SA Natl Cancer Inst Monogr; 1982 Jun; 61():183-92. PubMed ID: 7177177 [TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory pretreatment enables an efficient dendritic cell-based immunotherapy against established tumors. Chiarella P; Vulcano M; Bruzzo J; Vermeulen M; Vanzulli S; Maglioco A; Camerano G; Palacios V; Fernández G; Brando RF; Isturiz MA; Dran GI; Bustuoabad OD; Ruggiero RA Cancer Immunol Immunother; 2008 May; 57(5):701-18. PubMed ID: 17962945 [TBL] [Abstract][Full Text] [Related]
10. Effective immunotherapy against cancer: a question of overcoming immune suppression and immune escape? Malmberg KJ Cancer Immunol Immunother; 2004 Oct; 53(10):879-92. PubMed ID: 15338206 [TBL] [Abstract][Full Text] [Related]
11. Immunological aspects of cryosurgery in general surgery. Tanaka S Prog Clin Biol Res; 1982; 107():799-814. PubMed ID: 6891963 [No Abstract] [Full Text] [Related]
12. [Collagenous structures--one of the body's information systems]. Lebedev DA Usp Sovrem Biol; 1979; 88(4):36-49. PubMed ID: 45345 [No Abstract] [Full Text] [Related]
13. Reversal of tumor-induced immunosuppression: a new approach to cancer therapy. Wojtowicz-Praga S J Immunother; 1997 May; 20(3):165-77. PubMed ID: 9181454 [TBL] [Abstract][Full Text] [Related]
14. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis]. Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428 [TBL] [Abstract][Full Text] [Related]
15. The flip side of immune surveillance: immune dependency. Prehn RT; Prehn LM Immunol Rev; 2008 Apr; 222():341-56. PubMed ID: 18364013 [TBL] [Abstract][Full Text] [Related]
16. [The immune system and tissue proliferation, fetal tolerance and tumor growth]. Bukovský A; Prsl J Cesk Gynekol; 1984 Sep; 49(8):584-99. PubMed ID: 6388869 [No Abstract] [Full Text] [Related]
17. The central nervous system and the immune system. Fauman MA Biol Psychiatry; 1982 Dec; 17(12):1459-82. PubMed ID: 6130802 [No Abstract] [Full Text] [Related]
18. Immunity in malignant diseases. Alexander P S Afr J Surg; 1975 Sep; 13(3):101-4. PubMed ID: 1209418 [No Abstract] [Full Text] [Related]
19. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Smyth MJ; Dunn GP; Schreiber RD Adv Immunol; 2006; 90():1-50. PubMed ID: 16730260 [TBL] [Abstract][Full Text] [Related]
20. Harnessing self-reactivity in cancer immunotherapy. Schoenberger SP; Sercarz EE Semin Immunol; 1996 Oct; 8(5):303-9. PubMed ID: 8956459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]